Abstract
Previous experiments have suggested that nitric oxide plays an important role in nociceptive transmission in the spinal cord. In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of fluorocitrate (FC), an inhibitor of glial metabolism, on NOS expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats. Sixty adult male Sprague–Dawley rats were randomly assigned into sham, formalin, formalin + normal saline (NS), and formalin + FC groups. The NOS expression, NOS activity and NO production was detected by NADPH-d histochemistry staining, NOS and NO assay kit, respectively. It was found that formalin test significantly up-regulated NOS expression and activity and NO production in the laminae I–II of the dorsal horn and the grey matter around the central canal in the lumbar spinal cord at 1 h after the formalin test. Selective inhibition of glia metabolism with intrathecal administration of FC (1 nmol) significantly inhibited the up-regulation in NOS expression and activity and NO production normally induced by the formalin test, which was represented with decreases in the number and density of the NADPH-d positive cells in the dorsal horn and grey matter around the central canal, and decrease in density of NADPH-d positive neuropil in the dorsal horn in formalin + FC group compared with formalin group. The results suggested that glia may be involved in the NO-mediated nociceptive transmission in the spinal cord.
Similar content being viewed by others
References
Tassorelli C, Greco R, Wang D et al (2003) Nitroglycerin induces hyperalgesia in rats-a time-course study. Eur J Pharmacol 464:159–162. doi:10.1016/S0014-2999(03)01421-3
Inoue T, Mashimo T, Shibata M et al (1998) Rapid development of nitric oxide-induced hyperalgesia depends on an alternate to the cGMP-mediated pathway in the rat neuropathic pain model. Brain Res 792:263–270. doi:10.1016/S0006-8993(98)00147-4
Holguin A, O’Connor KA, Biedenkapp J et al (2004) HIV-1 gp120 stimulates proinflammatory cytokine-mediated pain facilitation via activation of nitric oxide synthase-I (nNOS). Pain 110:517–530. doi:10.1016/j.pain.2004.02.018
Zanchet EM, Longo I, Cury Y (2004) Involvement of spinal neurokinins, excitatory amino acids, proinflammatory cytokines, nitric oxide and prostanoids in pain facilitation induced by Phoneutria nigriventer spider venom. Brain Res 1021:101–111. doi:10.1016/j.brainres.2004.06.041
Lui PW, Lee CH (2004) Preemptive effects of intrathecal cyclooxygenase inhibitor or nitric oxide synthase inhibitor on thermal hypersensitivity following peripheral nerve injury. Life Sci 75:2527–2538. doi:10.1016/j.lfs.2004.04.033
Sun XC, Li WB, Li SQ et al (2003) Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord. Sheng Li Xue Bao 55:677–683
Zeng JB, Li WB, Li QJ et al (2001) MK-801 attenuates NOS expression and NO content in the spinal cord of rats with inflammatory pain. Sheng Li Xue Bao 53:55–60
Watkins LR, Maier SF (2002) Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 82:981–1011
Schoeniger-Skinner DK, Ledeboer A, Frank MG et al (2007) Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain Behav Immun 21:660–667. doi:10.1016/j.bbi.2006.10.010
Lee IH, Lee IO (2005) Preemptive effect of intravenous ketamine in the rat: concordance between pain behavior and spinal fos-like immunoreactivity. Acta Anaesthesiol Scand 49:160–165. doi:10.1111/j.1399-6576.2004.00568.x
Richard S, Engblom D, Paues J et al (2005) Activation of the parabrachio-amygdaloid pathway by immune challenge or spinal nociceptive input: a quantitative study in the rat using Fos immunohistochemistry and retrograde tract tracing. J Comp Neurol 481:210–219. doi:10.1002/cne.20384
Meller ST, Dykstra C, Grzybycki D et al (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33:1471–1478. doi:10.1016/0028-3908(94)90051-5
Watkins LR, Martin D, Ulrich P et al (1997) Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71:225–235. doi:10.1016/S0304-3959(97)03369-1
Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109–110. doi:10.1016/0304-3959(83)90201-4
Mestre C, Pélissier T, Fialip J et al (1994) A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 32:197–200. doi:10.1016/1056-8719(94)90087-6
Lalatta-Costerbosa G, Mazzoni M, Clavenzani P et al (2007) Nitric oxide synthase immunoreactivity and NADPH-d histochemistry in the enteric nervous system of Sarda breed sheep with different PrP genotypes in whole-mount and cryostat preparations. J Histochem Cytochem 55:387–401. doi:10.1369/jhc.6A7052.2007
Labombarda F, Gonzalez S, Roig P et al (2000) Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured rat spinal cord. J Steroid Biochem Mol Biol 73:159–169. doi:10.1016/S0960-0760(00)00064-9
Gonzalez Deniselle MC, Gonzalez SL, Lima AE et al (1999) The 21-aminosteroid U-74389F attenuates hyperexpression of GAP-43 and NADPH-diaphorase in the spinal cord of wobbler mouse, a model for amyotrophic lateral sclerosis. Neurochem Res 24:1–8. doi:10.1023/A:1020918310281
Vincent SR, Kimura H (1992) Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46:755–784. doi:10.1016/0306-4522(92)90184-4
Zhao H-G, Sun X-C, Xian X-H et al (2007) The role of nitric oxide in the neuroprotection of limb ischemic preconditioning in rats. Neurochem Res 32:1919–1926. doi:10.1007/s11064-007-9381-2
Feng M, Liu L, Guo Z et al (2008) Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Eur J Pharmacol 584:49–56. doi:10.1016/j.ejphar.2008.01.029
Porro CA, Cavazzuti M (1993) Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog Neurobiol 41:565–607. doi:10.1016/0301-0082(93)90044-S
Guo W, Wang H, Watanabe M et al (2007) Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 27:6006–6018. doi:10.1523/JNEUROSCI.0176-07.2007
Wieseler-Frank J, Maier SF, Watkins LR (2004) Glial activation and pathological pain. Neurochem Int 45:389–395. doi:10.1016/j.neuint.2003.09.009
Watkins LR, Milligan ED, Maier SF (2001) Spinal cord glia: new players in pain. Pain 93:201–205. doi:10.1016/S0304-3959(01)00359-1
Milligan ED, Twining C, Chacur M et al (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23:1026–1040
Sweitzer SM, Schubert P, DeLeo JA (2001) Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297:1210–1217
Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450–455. doi:10.1016/S0166-2236(00)01854-3
Raghavendra V, Tanga FY, DeLeo JA (2004) Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 20:467–473. doi:10.1111/j.1460-9568.2004.03514.x
Tanga FY, Raghavendra V, DeLeo JA (2004) Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain. Neurochem Int 45:397–407. doi:10.1016/j.neuint.2003.06.002
Fu KY, Light AR, Matsushima GK et al (1999) Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 825:59–67. doi:10.1016/S0006-8993(99)01186-5
Sweitzer SM, Colburn RW, Rutkowski M et al (1999) Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat. Brain Res 829:209–221. doi:10.1016/S0006-8993(99)01326-8
Kim D, Kim MA, Cho IH et al (2007) A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 282:14975–14983. doi:10.1074/jbc.M607277200
Ohtori S, Takahashi K, Moriya H et al (2004) TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 29:1082–1088. doi:10.1097/00007632-200405150-00006
Popovich PG, Wei P, Stokes BT (1997) Cellular inflammatory response after spinal cord injury in Sprague–Dawley and Lewis rats. J Comp Neurol 377:443–464. doi:10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
Zhang RX, Liu B, Wang L et al (2005) Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia. Pain 118:125–136. doi:10.1016/j.pain.2005.08.001
Schwei MJ, Honore P, Rogers SD et al (1999) Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 19:10886–10897
Milligan ED, O’Connor KA, Nguyen KT et al (2001) Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21:2808–2819
Milligan ED, Mehmert KK, Hinde JL et al (2000) Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 861:105–116. doi:10.1016/S0006-8993(00)02050-3
Catania MV, Giuffrida R, Seminara G et al (2003) Upregulation of neuronal nitric oxide synthase in in vitro stellate astrocytes and in vivo reactive astrocytes after electrically induced status epilepticus. Neurochem Res 28:607–615. doi:10.1023/A:1022841911265
Haydon PG (2001) GLIA: listening and talking to the synapse. Nat Rev Neurosci 2:185–193. doi:10.1038/35058528
Urban MO, Gebhart GF (1999) Central mechanisms in pain. Med Clin North Am 83:585–596. doi:10.1016/S0025-7125(05)70125-5
Light AR, Perl ER (1979) Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol 186:133–150. doi:10.1002/cne.901860203
Nahin RL, Madsen AM, Giesler GJ Jr (1983) Anatomical and physiological studies of the gray matter surrounding the spinal cord central canal. J Comp Neurol 220:321–335. doi:10.1002/cne.902200306
Gonzalez S, Labombarda F, Gonzalez Deniselle MC et al (2001) Glucocorticoid effects on Fos immunoreactivity and NADPH-diaphorase histochemical staining following spinal cord injury. Brain Res 912:144–153. doi:10.1016/S0006-8993(01)02717-2
Acknowledgement
This study was supported by grants from The Department of Science and Technology of Hebei province of China (No.: 98276196D, 04276101D-77).
Author information
Authors and Affiliations
Corresponding author
Additional information
X.-C. Sun, W.-N. Chen and S.-Q. Li contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sun, XC., Chen, WN., Li, SQ. et al. Fluorocitrate, an Inhibitor of Glial Metabolism, Inhibits the Up-Regulation of NOS Expression, Activity and NO Production in the Spinal Cord Induced by Formalin Test in Rats. Neurochem Res 34, 351–359 (2009). https://doi.org/10.1007/s11064-008-9785-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-008-9785-7